ArticleMikrochimica acta2026
High-sensitivity SERS nanosensor for precise in situ tracking of caspase-1 during pyroptosis in macrophages.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Caspase-1 plays a pivotal role in the initiation and progression of pyroptosis. The accurate in situ detection of intracellular caspase-1 remains challenging due to its low abundance in macrophages and the structural similarity among caspase family members. Herein, we designed and developed an efficient surface-enhanced Raman scattering (SERS) nanosensor for the highly sensitive, selective, and precise monitoring of dynamic caspase-1 level changes in macrophages during pyroptosis. The nanosensor was constructed by assembling a peptide chain containing the Raman reporter molecule 4-PB onto Au@Au core-shell nanoparticles. This peptide chain can be specifically recognized and cleaved by caspase-1, causing the reporter molecule 4-(phenylethynyl)benzenethiol (4-PB) to detach from the surface of the Au@Au core-shell nanoparticles and thereby reducing the intensity of its fingerprint peaks (2212 cm− 1) located in the cellular Raman-silent region, which enables highly specific and accurate detection of caspase-1. The plasmonic enhancement effect generated within the nanogaps of the core-shell nanoparticles significantly improves the detection sensitivity for caspase-1. We successfully monitored the dynamic changes of caspase-1 in macrophages during adenosine triphosphate (ATP)-induced pyroptosis. This SERS-based nanosensing strategy holds promise for detecting the activity of caspase family members in living cells and may provide an important scientific reference for the diagnosis and prognostic assessment of related diseases.
Indexed as
Identifiers
41975162What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.